Drug
Arv 6723
Arv 6723: highest development phase Phase 1/2, developed by Arvinas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arvinas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARV-6723 NCT07749586 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Arv 6723 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.